Form 4 for ZBH Zimmer Biomet
Accepted 2022-03-21 00:00:00 ET · period of report 2022-03-17 · accession 0001062993-22-008198 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-21 | 2022-03-17 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | M - OptEx | $62.22 | +35.1K | 76.7K | +85% | +$2.19M |
| DM | 2022-03-21 | 2022-03-17 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | S - Sale+OE | $121.97 | -35.1K | 76.4K | -32% | -$4.29M |
| D | 2022-03-21 | 2022-03-17 | ZBH | Phipps Chad F | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -35.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | M | A | 35,149 | $62.22 | 76,688 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 9, 2022. (F2) Includes 387 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestment between April 28, 2021 and January 27, 2022. |
| 2 | Common | Common Stock | 2022-03-17 | S | D | 5,331 | $122.46 | 41,539 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 9, 2022. (F5) Reflects the weighted average price of 5,331 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2022 with sale prices ranging from $122.37 to $122.57 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2022-03-17 | S | D | 29,518 | $121.90 | 46,870 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 9, 2022. (F4) Reflects the weighted average price of 29,518 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2022 with sale prices ranging from $121.37 to $122.365 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2022-03-17 | S | D | 300 | $120.69 | 76,388 | D | — | — | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 9, 2022. (F3) Reflects the weighted average price of 300 shares of common stock of Zimmer Biomet Holdings, Inc. sold in multiple transactions on March 17, 2022 with sale prices ranging from $120.29 to $120.90 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuance, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Employee Stock Option (right to buy) | 2022-03-17 | M | D | 35,149 | $0.00 | 0 | D | $62.22 · 2016-03-19 to 2022-03-19 | 35,149 Common Stock | (F1) The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on March 9, 2022. |